Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    August 2018
  1. HAN J, Wang F, Lan Y, Wang J, et al
    KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
    Oncogene. 2018 Aug 16. pii: 10.1038/s41388-018-0440.
    PubMed     Text format     Abstract available


  2. LAI CY, Liu H, Tin KX, Huang Y, et al
    Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Oncogene. 2018 Aug 10. pii: 10.1038/s41388-018-0442.
    PubMed     Text format     Abstract available


  3. TOSHIYAMA R, Konno M, Eguchi H, Takemoto H, et al
    Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
    Oncogene. 2018 Aug 8. pii: 10.1038/s41388-018-0406.
    PubMed     Text format     Abstract available


  4. MENG J, Chen S, Lei YY, Han JX, et al
    Hsp90beta promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2018 Aug 7. pii: 10.1038/s41388-018-0428.
    PubMed     Text format     Abstract available


  5. YANG X, Qu S, Wang L, Zhang H, et al
    PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Oncogene. 2018 Aug 1. pii: 10.1038/s41388-018-0416.
    PubMed     Text format     Abstract available


    July 2018
  6. YANG Y, Wu XQ, Li WX, Huang HM, et al
    PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.
    Oncogene. 2018 Jul 11. pii: 10.1038/s41388-018-0383.
    PubMed     Text format     Abstract available


    June 2018
  7. KANDA M, Tanaka H, Shimizu D, Miwa T, et al
    SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0335.
    PubMed     Text format     Abstract available


    May 2018
  8. LIU H, Chen W, Zhi X, Chen EJ, et al
    Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0309.
    PubMed     Text format     Abstract available


  9. TAN S, Li H, Zhang W, Shao Y, et al
    NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Oncogene. 2018 May 21. pii: 10.1038/s41388-018-0280.
    PubMed     Text format     Abstract available


  10. PINATO DJ
    Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0262.
    PubMed     Text format    


    April 2018
  11. LABGAA I, Villacorta-Martin C, D'Avola D, Craig AJ, et al
    A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.
    Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0206.
    PubMed     Text format     Abstract available


    March 2018
  12. SU T, Liao J, Dai Z, Xu L, et al
    Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0169.
    PubMed     Text format     Abstract available


  13. EHEDEGO H, Mohs A, Jansen B, Hiththetiya K, et al
    Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0181.
    PubMed     Text format     Abstract available


  14. WANG J, Dong M, Xu Z, Song X, et al
    Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0188.
    PubMed     Text format     Abstract available


  15. DONG L, Yu L, Bai C, Liu L, et al
    USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.
    Oncogene. 2018 Mar 2. pii: 10.1038/s41388-018-0137.
    PubMed     Text format     Abstract available


    January 2018
  16. HUA S, Lei L, Deng L, Weng X, et al
    miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0057.
    PubMed     Text format     Abstract available


  17. LIU MX, Jin L, Sun SJ, Liu P, et al
    Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0070.
    PubMed     Text format     Abstract available


    December 2017
  18. GUO P, Wang Y, Dai C, Tao C, et al
    Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/beta-catenin-induced FGF18 expression in hepatocellular carcinoma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0017.
    PubMed     Text format     Abstract available


    November 2017
  19. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017;36:6747-6748.
    PubMed     Text format     Abstract available


  20. NAKATSUKA T, Tateishi K, Kudo Y, Yamamoto K, et al
    Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Oncogene. 2017;36:6262-6271.
    PubMed     Text format     Abstract available


    October 2017
  21. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    PubMed     Text format     Abstract available


  22. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Text format     Abstract available


  23. NAKAYAMA M, Sakai E, Echizen K, Yamada Y, et al
    Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Oncogene. 2017;36:5885-5896.
    PubMed     Text format     Abstract available


  24. GUO P, Ma X, Zhao W, Huai W, et al
    TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Oncogene. 2017 Oct 2. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  25. XIE X, Guo P, Yu H, Wang Y, et al
    Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  26. TRAN DDH, Kessler C, Niehus SE, Mahnkopf M, et al
    Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  27. FENG GX, Li J, Yang Z, Zhang SQ, et al
    Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  28. LI J, Huang Q, Long X, Guo X, et al
    Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
    Oncogene. 2017;36:4901-4912.
    PubMed     Text format     Abstract available


  29. HAN H, Yang B, Wang W
    Angiomotin-like 2 interacts with and negatively regulates AKT.
    Oncogene. 2017;36:4662-4669.
    PubMed     Text format     Abstract available


  30. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  31. GOVAERE O, Petz M, Wouters J, Vandewynckel YP, et al
    The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  32. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer.
    Oncogene. 2017;36:4405-4414.
    PubMed     Text format     Abstract available


    July 2017
  33. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  34. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  35. XIONG H, Ni Z, He J, Jiang S, et al
    LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Oncogene. 2017;36:3528-3540.
    PubMed     Text format     Abstract available


    May 2017
  36. CROSAS-MOLIST E, Bertran E, Rodriguez-Hernandez I, Herraiz C, et al
    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.
    Oncogene. 2017;36:3002-3014.
    PubMed     Text format     Abstract available


  37. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  38. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    March 2017
  39. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  40. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  41. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  42. BATTISTELLI C, Cicchini C, Santangelo L, Tramontano A, et al
    The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.
    Oncogene. 2017;36:942-955.
    PubMed     Text format     Abstract available


    September 2016
  43. HAASE G, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: